The PE Ratio as of September 2024 (TTM) for Revolution Medicines, Inc. (RVMD) is -11.25

According to Revolution Medicines, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -11.25. This represents a change of 23.25% compared to the average of -9.13 of the last 4 quarters.

Revolution Medicines, Inc. (RVMD) Historical PE Ratio (quarterly & annually)

How has RVMD PE Ratio performed in the past?

The mean historical PE Ratio of Revolution Medicines, Inc. over the last ten years is -20.66. The current -11.25 PE Ratio has changed 5.35% with respect to the historical average. Over the past ten years (40 quarters), RVMD's PE Ratio was at its highest in in the September 2022 quarter at -5.69. The PE Ratio was at its lowest in in the June 2019 quarter at -26.04.

Revolution Medicines, Inc. (RVMD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Revolution Medicines, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Revolution Medicines, Inc. (RVMD) Average PE Ratio

How has RVMD PE Ratio performed in the past?

The current PE Ratio of Revolution Medicines, Inc. (RVMD) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Revolution Medicines, Inc. (RVMD) PE Ratio vs. Peers

How is RVMD’s PE Ratio compared to its peers?

Revolution Medicines, Inc.’s PE Ratio is greater than Blueprint Medicines Corporation (-26.44), less than Sana Biotechnology, Inc. (-4.82), greater than Kymera Therapeutics, Inc. (-21.01), less than Monte Rosa Therapeutics, Inc. (-3.11), less than TCR2 Therapeutics Inc. (-0.44), less than Black Diamond Therapeutics, Inc. (-3.70), less than Atreca, Inc. (-0.04), less than Passage Bio, Inc. (-0.57), less than Akero Therapeutics, Inc. (-8.95), greater than Avidity Biosciences, Inc. (-17.14), less than Protagonist Therapeutics, Inc. (14.97), less than Stoke Therapeutics, Inc. (-7.92), less than Homology Medicines, Inc. (-0.01), less than C4 Therapeutics, Inc. (-3.44), less than Agios Pharmaceuticals, Inc. (-6.74), less than Nurix Therapeutics, Inc. (-8.82),

Build a custom stock screener for Revolution Medicines, Inc. (RVMD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revolution Medicines, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revolution Medicines, Inc. (RVMD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revolution Medicines, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.